Cyproheptadine + Tricholine Citrate

Cyproheptadine + Tricholine Citrate Syrup is positioned within the Syrups segment across Hepatology, Liver Care, and General Wellness therapeutic portfolios. Unlike simple vitamin or nutritional tonics, this combination delivers a pharmacologically active appetite mechanism alongside hepatic nutritional support — giving prescribers a dual rationale for recommendation.

Cyproheptadine Hydrochloride is a first-generation antihistamine with a particularly pronounced serotonin-antagonist (5-HT2) activity. Its appetite-stimulating property arises from its ability to reduce serotonergic satiety signaling in the hypothalamus — making it the active driver of the product’s appetite-enhancing clinical story. Because it crosses the blood-brain barrier, it also produces mild sedation, which must be managed through proper patient counseling and label compliance.

Tricholine Citrate provides a bioavailable choline source, addressing the nutritional and hepatic dimension of appetite-related disorders. Choline is essential for phosphatidylcholine synthesis, bile production, and lipid metabolism. In hepatobiliary conditions where appetite loss and fatty liver co-exist, Tricholine Citrate supports liver function alongside the appetite stimulation provided by Cyproheptadine.

For pharmaceutical marketing companies, this product commands strong repeat prescription cycles because poor appetite is a persistent complaint across post-illness recovery, hepatic disorders, adolescent growth, and elderly nutritional inadequacy. Saar Biotech manufactures it from our manufacturing facility in Baddi with controlled liquid oral processing, premium flavour development, and flexible packaging for both economy and premium brand positions.

At Saar Biotech, we manufacture Cyproheptadine Tricholine Citrate Syrup using a controlled oral syrup manufacturing process that prioritizes consistent dose delivery, long-term flavour stability, and commercially competitive packaging finishes for the 200 ml appetite syrup format.

• Repeat-Use Palatability Engineering: Appetite syrups are used daily over extended periods — meaning the flavour must remain pleasant from the first spoonful to the last. Saar Biotech’s R&D team uses balanced sweetener and flavour systems in Chocolate, Orange, Raspberry, and Pineapple directions, ensuring the bitterness of Cyproheptadine HCl does not surface with repeated dosing or temperature fluctuations during storage.

• Active Distribution Uniformity: Both Cyproheptadine and Tricholine Citrate must be uniformly dissolved and distributed through the syrup base to ensure every 5 ml dose delivers the full 2 mg + 275 mg label claim. Our in-process mixing controls and fill-volume checks support consistent dose delivery across 100 ml and 200 ml commercial packs.

• 200 ml Premium Packaging Execution: The 200 ml format is the dominant commercial pack for appetite syrups. We support drip-off embossed cartons (320–330 GSM), metallic sticker labels, silver or gold leafing, company-logo printed PP caps, measuring caps, and UV-finish cartons — giving B2B partners the visual differentiation needed to compete at pharmacy shelf level.

• Colour and Flavour Matching: Chocolate, orange, raspberry, and pineapple profiles are paired with appropriate colour systems to create a visually coherent and market-standard product appearance. This matters for appetite syrup brands where consumer perception of colour and taste drives repeat purchase.

This manufacturing discipline ensures your Cyproheptadine Tricholine third-party brand delivers reliable appetite support, consistent sensory quality, and professional retail presentation from every batch.

Cyproheptadine + Tricholine Citrate Syrup is manufactured and supplied by Saar Biotech for the following clinically established indications, making it a high-frequency prescription product in general medicine, hepatology, and post-illness recovery segments.

• Appetite Loss & Anorexia: The primary indication. Cyproheptadine’s antiserotonergic action reduces early satiety and helps revive the desire to eat in patients with clinically significant appetite loss. Particularly relevant in post-illness recovery, nutritional depletion states, and anorexia-associated weight loss.

• Hepatobiliary Disorders with Anorexia: Liver conditions frequently impair appetite. The combination of Cyproheptadine for appetite stimulation and Tricholine Citrate for hepatic lipid metabolism support makes this a pharmacologically rational choice for hepatology-directed prescriptions.

• Weight Gain Support in Nutritional Inadequacy: Used where inadequate food intake is the primary barrier to nutritional recovery. Improved appetite under medical supervision may help restore caloric intake as part of a broader nutritional management plan.

• General Wellness and Recovery Portfolios: For pharma marketing companies, this syrup fits naturally in liver tonic, digestive health, and recovery segment portfolios. It should be positioned responsibly as physician-supervised supportive therapy.

This product requires medical supervision. Use under physician advice only.

Dual-Mechanism Clinical Logic

Cyproheptadine HCl acts as an inverse agonist at H1 histamine receptors and a competitive antagonist at 5-HT2 serotonin receptors. The appetite-stimulating effect is predominantly attributed to 5-HT2 antagonism in the hypothalamic feeding-control centers, where serotonin normally suppresses hunger. By reducing this suppression, Cyproheptadine allows appetite to be re-engaged without relying on stimulant or hormonal mechanisms. Its H1 antihistamine activity also contributes mild sedation — an effect that should be counseled for and managed in daily use.

Tricholine Citrate delivers free choline after citrate ester hydrolysis. Choline is a lipotropic agent incorporated into phosphatidylcholine, which is essential for VLDL formation and hepatic fat export. In patients with hepatic steatosis or impaired bile production — both common in anorexia and liver disease — supplementing choline through Tricholine Citrate helps support hepatic lipid clearance alongside the appetite-stimulating therapy.

Manufacturing Integrity

• Flavour Longevity & Bitterness Control: Cyproheptadine HCl has a detectably bitter character that can compromise patient compliance if the syrup base is not engineered carefully. Our formulation team builds in sweetener-layering and flavour-timing systems that ensure the bitterness is masked from first taste to final dose — essential for a product used over 100 ml or 200 ml repeat consumption.

• Syrup Matrix Stability: The formulation must remain stable in colour, flavour character, and active distribution through its 24-month shelf life under Indian tropical storage conditions. Saar Biotech’s excipient selection and pH control strategies prevent flavour drift, colour changes, or active precipitation during storage and distribution.

Cyproheptadine Tricholine Citrate Syrup’s B2B appeal is anchored in high prescription familiarity, a clear two-part clinical story, and the commercial dominance of the 200 ml repeat-use format.

• Rapid Oral Absorption: Cyproheptadine is well absorbed from the gastrointestinal tract. Appetite effects may be noticed within a few days of consistent use, which gives the brand a relatively observable clinical outcome that supports prescriber and patient confidence.

• Liver-Support Commercial Angle: Tricholine Citrate adds a hepatoprotective narrative that differentiates this product from plain antihistamine appetite syrups. This allows pharma marketing companies to position it across both hepatology and general wellness prescriptions — widening the addressable market without adding complexity.

• Repeat-Purchase 200 ml Format: Appetite and liver-support products are typically used over weeks or months. A 200 ml bottle provides enough volume for extended use, reducing prescription refill friction and encouraging consistent adherence — both important metrics for brand prescription loyalty.

• Flavour-Driven Market Differentiation: In a crowded appetite syrup segment, flavour is a genuine differentiator. A chocolate or raspberry variant can create a distinct brand identity that improves recall with pharmacists and distributors, especially in regions where the category has many look-alike competitors.

Saar Biotech offers specialized Third-Party Manufacturing and Contract Manufacturing services for Cyproheptadine Tricholine Citrate Syrup from our oral liquid manufacturing facility in Baddi, Himachal Pradesh.

• Facility: Dedicated oral liquid manufacturing block with controlled syrup processing, automated bottle filling, capping, labeling, and carton packing lines for 100 ml and 200 ml presentations.
• Capacity: Scalable from brand-entry batch sizes to high-volume 60×200 ml, 72×200 ml distributor dispatch configurations for commercial supply.
• Quality Lab: In-house GLP-certified lab performing assay, pH, viscosity, MLT, fill volume, colour, and appearance checks on every batch.
• Turnaround: New orders — 30 to 45 working days from artwork and documentation finalization. Repeat orders — 20 to 25 working days.
• Packaging: Full range — 100 ml and 200 ml bottles, sticker label, metallic label, silver/gold leafing, drip-off embossed carton, UV finish, measuring caps, company-logo printed PP caps, with-carton and without-carton options.
• MOQ: Starting at 5,000–10,000 units per SKU; high-volume configurations available for established distributors.

1. Warehouse Storage: Store sealed cartons below 30°C in a cool, dry place. Excessive heat can alter the flavour character, syrup viscosity, and colour tone — all of which affect consumer perception of appetite syrups.
2. Light & Closure Protection: Keep bottles tightly closed and protected from direct sunlight. Amber or suitable pharmaceutical-grade bottles with outer cartons preserve the product’s appearance during transport and pharmacy shelf display.
3. Measuring Cap Use: A measuring cap is recommended for 200 ml packs to ensure accurate 5 ml dosing and to give the pack a more complete, professional presentation at pharmacy level.
4. Premium Pack Handling: Drip-off, metallic, embossed, and leafing-finish cartons should be packed to avoid scuffing during transit — particularly important for brands competing on shelf premium presentation.

Every batch of Cyproheptadine Tricholine Citrate Syrup is quarantined until it passes a comprehensive analytical release protocol:

• Assay (Label Claim Accuracy): Cyproheptadine HCl 2 mg and Tricholine Citrate 275 mg per 5 ml are confirmed against declared specifications to ensure every bottle reaches the pharmacy shelf at full therapeutic strength.
• pH & Syrup Consistency: pH is monitored to maintain formulation stability and palatability. Syrup consistency checks ensure clean pourability into measuring caps and consistent mouthfeel across the shelf life.
• Appearance, Colour & Flavour Evaluation: Batch-to-batch colour uniformity and expected flavour character are confirmed — critical for chocolate, orange, raspberry, and pineapple variants where sensory consistency is part of the brand promise.
• Microbial Limit Testing (MLT): Oral syrups used over extended periods require strict microbiological quality control. Every batch is verified to meet IP MLT specifications before release.
• Fill Volume & Packaging Inspection: Automated fill-volume checks, cap torque, label placement, carton finish, and measuring-cap inclusion are verified before dispatch — especially important for premium 200 ml packs with embossed or leafing carton finishes.
• Certificate of Analysis (COA): Issued with every B2B batch for partner documentation and regulatory records.

• Common Side Effects: Drowsiness, dry mouth, dizziness, confusion, constipation, blurred vision, or mild gastrointestinal discomfort may occur. Patients must avoid alcohol and activities requiring alertness if sedation is experienced.
• Contraindications: Known hypersensitivity to Cyproheptadine or any component. Avoid in patients with angle-closure glaucoma, urinary retention, or those receiving MAO inhibitor therapy.
• Drug Interactions: Alcohol, sedatives, tranquilizers, hypnotics, CNS depressants, and MAO inhibitors can significantly potentiate the sedative and anticholinergic effects of Cyproheptadine.
• Healthcare professionals should review full prescribing information before recommending in children under physician supervision, elderly patients, pregnant or lactating women, and patients with significant hepatic or renal impairment.

For third-party manufacturing enquiries, private-label contracts, or pricing for Cyproheptadine HCl + Tricholine Citrate Syrup, please use the B2B enquiry form below.